Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploid Hematopoietic Stem Cell Transplantation: a Prospective, Multicenter Study

NCT07698080 is registered in ClinicalTrials.gov with Hematology department of the 920th hospital as lead sponsor.

NCT NCT07698080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploid Hematopoietic Stem Cell Transplantation: a Prospective, Multicenter Study
Lead sponsor
Hematology department of the 920th hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 3, 2026
Completion date
July 3, 2028
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia, leukemia, lymphoma, myelodysplastic syndromes, thalassemia